A randomized controlled multicenter trial of Rebamipide on chronic non-atrophic gastritis
	    		
		   		
	    	
    	
    	
   		
        
        	
        		- VernacularTitle:瑞巴派特治疗慢性非萎缩性胃炎的随机、对照、多中心临床研究
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Yiqi DU
			        		
			        		;
		        		
		        		
		        		
			        		Zhaoshen LI
			        		
			        		;
		        		
		        		
		        		
			        		Xianbao ZHAN
			        		
			        		;
		        		
		        		
		        		
			        		Duowu ZOU
			        		
			        		;
		        		
		        		
		        		
			        		Jie CHEN
			        		
			        		;
		        		
		        		
		        		
			        		Yanfang GONG
			        		
			        		;
		        		
		        		
		        		
			        		Jianlin REN
			        		
			        		;
		        		
		        		
		        		
			        		Liping HE
			        		
			        		;
		        		
		        		
		        		
			        		Zhijian ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Xiaozhong GUO
			        		
			        		;
		        		
		        		
		        		
			        		Jianshen WU
			        		
			        		;
		        		
		        		
		        		
			        		Zibin TIAN
			        		
			        		;
		        		
		        		
		        		
			        		Ruihua SHI
			        		
			        		;
		        		
		        		
		        		
			        		Bo JIANG
			        		
			        		;
		        		
		        		
		        		
			        		Dianchun FANG
			        		
			        		;
		        		
		        		
		        		
			        		Youming LI
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Rebamipide;
			        		
			        		
			        		
				        		Chronic non-atrophic gastritis;
			        		
			        		
			        		
				        		Helieobacter pylori
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Digestive Endoscopy
	            		
	            		 2008;25(7):353-358
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To investigate the effect of rebamipide on chronic non-atrophic gastritis (NAG) with erosion and its protection of gastric mucosa from Helicobacter priori(Hp) associated lesions.Methods Patients(n=452)with endoscopically confirmed NAG with erosion from 11 hospitals in China were enrolled and randomly assigned at a ratio of 3:1 to receive either rebamipide(100 mg t.i.d.)or sucralfate(1.0 t.i.d.)for 8 weeks.Hp infected patients received eradication treatment before randomization.Symptoms,endoscopic scores and histological changes were recorded before and after therapy.Concentrations of serum prostaglandin E(PGE:)and oxygen free radical(MDA)were measured in patients from 2 centers.Results Per-protocol analysis(n=415)showed that the dyspeptic symptom score in rebamipide group decreased significantly after eight weeks of treatment. The endoscopic inflammation score in rebamipide group also decreased from 2.65 ±0.09 to 0.60±0.10(P<0.001),which was,significantly better than that of sucralfate group(P<0.001).Histological findings were consistent with the endoscopic findings.There Was a significant elevation(P=0.002)in PGE2 concentration in mucesa from rebamipide-treated subjects [(225.4±18.3) pg/g vs.(266.7±14.7)Pg/g] compared with that in sucralfate group.The concentration of MDA significantly decreased from(325.9±65.6)mmoL/g to(216.5±61.5)mmol/g,which is markedly different from that of sucralfate group(P=0.046).No statistical difference was found between Hp eradication group,Hp infection group and Hp negative group,regarding the effect of Rebamipide.Conclusion Compared to sucralfate,Rebamipide demonstrates a superior effect on improvement of dyspepsia symptom and endoscopic findings in erosive NAG,which is not influenced by Hp infection.